We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$14.1B
1-Year Est. Return
30.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
SOLS
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
1626
DELISTED
Esperion Therapeutics
ESPR
| $57.5K | ﹤0.01% |
20,974
+2,888
| +16% | +$9.14K |
|
1627
indie Semiconductor
INDI
$799M
| $57.3K | ﹤0.01% |
17,796
+2,399
| +16% | +$8.47K |
|
1628
FTAI Infrastructure
FIP
$473M
| $56.5K | ﹤0.01% |
11,447
+1,254
| +12% | +$7.02K |
|
1629
Gevo
GEVO
$424M
| $56.2K | ﹤0.01% |
20,601
+2,805
| +16% | +$5.81K |
|
1630
UWM Holdings
UWMC
$641M
| $54.7K | ﹤0.01% |
15,117
+4,611
| +44% | +$21.2K |
|
1631
Hertz
HTZ
$553M
| $53.8K | ﹤0.01% |
11,681
+1,243
| +12% | +$6.01K |
|
1632
Ironwood Pharmaceuticals
IRWD
$639M
| $50.3K | ﹤0.01% |
14,337
+1,918
| +15% | +$7.86K |
|
|
RZLV
1633
Rezolve AI
RZLV
$921M
| $48.8K | ﹤0.01% |
19,068
+5,049
| +36% | +$14.2K |
|
1634
Sabre
SABR
$680M
| $48.1K | ﹤0.01% |
33,167
+3,941
| +13% | +$5.25K |
|
1635
Banco Bradesco
BBD
$37.8B
| $46.5K | ﹤0.01% |
+12,734
| New | +$48.3K |
|
1636
Cytek Biosciences
CTKB
$595M
| $46.3K | ﹤0.01% |
+10,593
| New | +$50K |
|
1637
AMC Entertainment Holdings
AMC
$2.11B
| $45.9K | ﹤0.01% |
46,830
+5,946
| +15% | +$7.65K |
|
|
NB
1638
NioCorp Developments
NB
$614M
| $45.8K | ﹤0.01% |
+10,278
| New | +$58.9K |
|
1639
Solid Power
SLDP
$520M
| $45.7K | ﹤0.01% |
15,244
+3,347
| +28% | +$13.5K |
|
1640
FerroAtlántica
GSM
$611M
| $43.9K | ﹤0.01% |
+10,659
| New | +$51.4K |
|
1641
Sana Biotechnology
SANA
$868M
| $43.4K | ﹤0.01% |
15,080
+2,012
| +15% | +$7.92K |
|
1642
Opko Health
OPK
$906M
| $42.5K | ﹤0.01% |
37,294
+4,933
| +15% | +$6.07K |
|
1643
MiMedx Group
MDXG
$643M
| $42.4K | ﹤0.01% |
+10,723
| New | +$54K |
|
|
BDN
1644
Brandywine Realty Trust
BDN
$539M
| $42.3K | ﹤0.01% |
15,621
+2,065
| +15% | +$6.18K |
|
1645
Clean Energy Fuels
CLNE
$489M
| $38.7K | ﹤0.01% |
15,622
+2,084
| +15% | +$4.86K |
|
1646
Bit Digital
BTBT
$551M
| $37.8K | ﹤0.01% |
28,828
+3,858
| +15% | +$7.08K |
|
1647
Absci
ABSI
$1.39B
| $36.5K | ﹤0.01% |
12,160
+1,635
| +16% | +$4.73K |
|
1648
iHeartMedia
IHRT
$596M
| $36.2K | ﹤0.01% |
12,398
+1,459
| +13% | +$4.83K |
|
1649
Kopin
KOPN
$706M
| $35.2K | ﹤0.01% |
15,661
+2,047
| +15% | +$4.96K |
|
|
AIOT
1650
PowerFleet Inc
AIOT
$580M
| $34.5K | ﹤0.01% |
+11,186
| New | +$46.9K |
|
Similar funds
CM
ETC
BIP
FGP
BPC
SSA
TI
BBVA
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.